Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Document › Details

Stratec Biomedical AG. (1/12/15). "Press Release: Marketing Agreement between Artel and Stratec". Birkenfeld.

Organisations Organisation Stratec Biomedical AG (Frankfurt: SBS, Prime Standard, TecDAX)
  Group Stratec (Group)
  Organisation 2 Artel (USA)
Products Product Tholos liquid handling quality assurance instrumentation solution
  Product 2 automated liquid handling technology
Index term Index term Artel–Stratec: liquid handling technology, 201501– distribution excl marketing of Tholos liquid handling quality assurance instrumentation solution
Persons Person Pilcher, Kirby (Artel 200606 President)
  Person 2 Wolfinger, Marcus (Stratec Biomedical 201104 CEO before CFO)
     


STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, TecDAX) and Artel, Westbrook, Maine, USA, the worldwide leader in laboratory liquid handling quality assurance, have announced an exclusive marketing agreement for STRATEC’s patented “Tholos” liquid handling quality assurance instrumentation solution.

Under the agreement, effective as of January 1, 2015, Artel will exclusively market the “Tholos” technology developed by STRATEC under Artel’s brand name in its core markets.

STRATEC’s “Tholos” measures the volume of liquids in reaction wells using an innovative pressure-based technology that accurately and repeatedly assesses volume regardless of the size of the reaction well, its shape or coloring. This makes it possible to record critical process parameters for sample handling operations in laboratory applications in the pharmaceutical industry, life science research, production and assay development. The system can therefore be used as an in-process control for nearly all types of liquid handling applications.

“Our customers will benefit from this powerful technology, which further enhances their ability to ensure high-quality results”, says Kirby Pilcher, president of Artel. “The strategic partnership with STRATEC, a leader in providing automated systems used in laboratories worldwide, has resulted in a perfect addition to Artel’s portfolio of liquid handling quality assurance products and services”.

“The system is an innovative volume control solution that closes a gap in in-process control for high throughput automation processes”, added Marcus Wolfinger, Chairman, Board of Management of STRATEC. “We are very proud to have gained Artel, the global market leader in liquid handling quality assurance, as a partner”.


About Artel

Laboratories worldwide depend upon Artel technology and expertise to standardize and optimize their liquid handling instruments and processes, and to give them total confidence in their results. Since 1982, Artel has been solving liquid handling quality, productivity and compliance challenges in laboratories in pharmaceutical and biotechnology research, regulatory bodies, academia, clinical diagnostics, forensics, public health, agbio, food quality and safety and environmental testing.

Artel provides quality assurance systems and a broad and fully customizable range of support, training and consultation services for laboratories using automated liquid handling instrumentation and manual pipettes. For more information visit www.artel-usa.com.


About STRATEC

STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies.
Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the TecDAX select index of the German Stock Exchange.


Further information can be obtained from:

STRATEC Biomedical AG
André Loy, Corporate Communications
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
ir@stratec.com
www.stratec.com

   
Record changed: 2017-04-02

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for Stratec (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top